Problematic 'high grade' lesions in lymphoproliferative pathology

Snjezana Dotlic
Snjezana Dotlic

Published: 01.12.2011.

Biochemistry

Volume 28, Issue 2 (2012)

pp. 498-500;

https://doi.org/10.5937/matmed1202498d

Abstract

References

1.
Lester. The clinical impact of expert pathological review on lymphoma management: a regional experience. Br.jHaematol. 2003;463–8.
2.
Campo E, Harris N. 2008;
3.
Chan Jk F, Cd, Nayler Sj, Cooper K. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer. 1997;294–313.
4.
Pileri Sa, Grogan T, Harris N. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma study Group based on 61 cases. Histopathology. 2002;1–29.
5.
C, C, Rd G. anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis. jClinOncol. 2009;4211–6.
6.
Adams H, Tzankov. Cytokeratin expression in hematological neoplasms: a tissue microarray study on 866 lymphoma and leukemia cases. Pathol.resPract. 2008;569–73.
7.
Mhawech-Fauceglia P, Zhang S. Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis. jClinPathol. 2007;709–14.
8.
Spier C, Lippman Sm, Miller T, Grogan T. Lennert’s lymphoma. a clinicopathologic study with emphasis on phenotype and its relationship to survival. Cancer. 1988;517–24.
9.
Es M. Granulomatous reaction in Burkitt lymphoma: correlation with EBV positivity and clinical outcome. am.j.surgPathol. 2005;1115–6.
10.
Es, Harris N, Vardiman Jw, Campo E, Da, Hematopathology. 2011;
11.
Bentink. High myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas. Int.jCancer. 2011;
12.
Hummel M, Bentink, Berger H. a biologic definition of Burkitt’s lymphoma from transcriptional and genomic profiling. NEngl.jMed. 2006;2419–30.
13.
Es. Pittaluga s. aggressive B-cell lymphomas: a review of new and old entities in the WHO classification. Hematology.am.socHematolEducProgram. 2011;506–14.
14.
Barrans S, Crouch. rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. jClinOncol. 2010;3360–5.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners